đŸ’„â€œMito-Energy” 8 week Protocol (SS-31/MotsC/NAD)

🧬The Scientific Synergy: How They Work Together

To maximize daytime energy, you can't just throw fuel into a broken engine. This protocol relies on a strict sequential logic:

đŸȘ›Â Step 1: Repair with SS-31 (The Architect):

SS-31 acts like a skilled repair crew. It helps stabilize a key part of the factory’s infrastructure (cardiolipin), patching up the leaks and improving the flow of materials through the system. As a result, less energy is wasted, the machinery runs more efficiently, and the factory is better prepared to produce the energy your cells rely on.

Simple Takeaway:
🍊 SS-31 repairs the factory.
🍎 It fixes leaks, reduces waste, and helps mitochondria run more efficiently before the next phase of support begins. (Campbell et al., 2019; Sun, n.d.).

đŸ› ïžÂ Step 2: Production with MOTS-c (The General Manager):

After the factory is repaired, it’s time to increase production.

MOTS-c acts like a general manager who improves efficiency, adds workers, and builds new production lines to meet demand.

Inside your cells, MOTS-c helps fuel get used more efficiently and encourages the creation of new mitochondria, expanding your energy-producing capacity.

Simple Takeaway:
🍊 SS-31 repairs the factory.
🍎 MOTS-c expands the factory. (Gao et al., 2023).

 ⛜Step 3: Fuel with NAD+ (The Premium Gasoline):

After the factory is repaired, it’s time to turn on the power. NAD+ acts like a premium fuel that fills up the newly fixed machines so they can run at 100% without overheating or smoking.
Inside your cells, NAD+ helps you create maximum energy with almost zero cellular waste.
Simple Takeaway:
🍊 SS-31 repairs the factory.
🍏 NAD+ fuels the factory. (Zhu et al., 2022). (Zhu et al., 2022).


đŸ› ïž Phase 1: The Repair Phase (Weeks 1–4)


Focus: Clear out cellular debris, stabilize mitochondrial membranes, and prep the engine using SS-31.

Week 1 & Week 2 (The Loading Period)

 SS-31 (~$280 ) : 4 mg daily, injected subcutaneously (Mon–Fri; take weekends off).
 

⏰ Timing: First thing in the morning on an empty stomach.
đŸ€” What to expect: No major "jolt" of energy, but a steady baseline clarity and improved physical recovery.

--------

Week 3 & Week 4 (The Taper Period)

SS-31 (~$140) : 2 mg daily, injected subcutaneously (Mon–Fri; take weekends off).
 ❓Why the drop? Your membrane cardiolipin levels are stabilized; you are dropping to a maintenance dose to prepare for the fueling phase.


⚡ Phase 2: The Fuel & Power Phase (5-8)


Focus: Build new power plants with MOTS-c and drop in premium coenzyme fuel with NAD+.


Week 5 & Week 6 (The Introduction)

 MOTS-c (~$80): 10 mg total per week, split into two 5 mg subcutaneous injections (e.g., Tuesday and Friday).
 ⏰Timing: Pin this immediately before a workout or a highly active morning.
 NAD+ (<$50): 20 mg to 50 mg daily, injected subcutaneously (Mon–Fri; weekends off).
 ⏰Timing: Pin this at least 30–60 minutes after your workout, right before your deepest focus work block.
 Crucial: Start at 20 mg to test your tolerance to the temporary chest flush/nausea.


Week 7 & Week 8 (The Peak)

 MOTS-c (~$80): 10 mg total per week, split into two 5 mg subcutaneous injections (e.g., Tuesday and Friday).
 NAD+ (<$100): Scale up to 50 mg to 100 mg daily, subcutaneous (Mon–Fri; weekends off).
 Note: Only scale up if the introductory dose didn't cause excessive anxiety or sleep disruption.

 

⏱ Quick Summary of Daily Rules

1. Never pin NAD+ after 12:00 PM (Noon): Doing so will intensely disrupt your evening melatonin production and ruin your sleep cycles.
2. Move on MOTS-c days: Make sure the days you pin MOTS-c involve at least 20–30 minutes of physical movement to activate the metabolic pathways it utilizes.
3. Take a hard reset: On Week 9, stop all three compounds entirely for 4 to 6 weeks to allow your native endocrine and cellular systems to run on their new, upgraded baseline.


References:


BallarĂČ, R., Lopalco, P., Audrito, V., BeltrĂ , M., Pin, F., Angelini, R., Costelli, P., Corcelli, A., Bonetto, A., Szeto, H. H., O’Connell, T. M., & Penna, F. (2021). Targeting Mitochondria by SS-31 Ameliorates the Whole Body Energy Status in Cancer- and Chemotherapy-Induced Cachexia. Cancers, 13(4), 850. https://doi.org/10.3390/cancers13040850

Cited by: 65

Campbell, M. D., Duan, J., Samuelson, A. T., Gaffrey, M. J., Merrihew, G. E., Egertson, J. D., Wang, L., Bammler, T. K., Moore, R. J., White, C. C., Kavanagh, T. J., Voss, J. G., Szeto, H. H., Rabinovitch, P. S., MacCoss, M. J., Qian, W.-J., & Marcinek, D. J. (2019). Improving mitochondrial function with SS-31 reverses age-related redox stress and improves exercise tolerance in aged mice. Free Radical Biology and Medicine, 134, 268–281. https://doi.org/10.1016/j.freeradbiomed.2018.12.031

Cited by: 149

Gao, Y., Wei, X., Wei, P., Lu, H., Zhong, L., Tan, J., Liu, H., & Liu, Z. (2023). MOTS-c Functionally Prevents Metabolic Disorders. Metabolites, 13(1), 125. https://doi.org/10.3390/metabo13010125

Cited by: 31

Sun, S. (n.d.). Mitochondria-targeted nanotechnology in cardiovascular diseases: a review of recent advances. Regenerative Biomaterials. https://doi.org/10.1093/rb/rbag040

Zheng, Y., Wei, Z., & Wang, T. (2023). MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitation. Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1120533

Cited by: 52

Zhu, Y., Luo, M., Bai, X., Li, J., Nie, P., Li, B., & Luo, P. (2022). SS-31, a Mitochondria-Targeting Peptide, Ameliorates Kidney Disease. Oxidative Medicine and Cellular Longevity, 2022, 1–13. https://doi.org/10.1155/2022/1295509

Cited by: 76